Ndepụta ọgwụ ụra nyocha
Nke a bụ ndepụta nke ọgwụ ụra nyocha, ma ọ bụ ọgwụ ahụ nwere ike ịbelata ọtụtụ ndị na eme ka ndị mmadụ n'ihe ọgwụ maka ọgwụgwọ nke nsogbu ụra nke na-emepe emepe ugbu a maka iji ya eme ihe n'ụlọ ọgwụ mana a kwadoghị ya. A na-edepụta aha kemịkal / n'ozuzu mbụ, na aha koodu mmepe, synonyms, na aha akara na parentheses.
Enweghị ụra
[dezie | dezie ebe o si]Ndị na-anabata GABAA
[dezie | dezie ebe o si]- EVT-201 - GABAA receptor positive allosteric modulator
- Lorediplon (GF-015535-00) - GABAA receptor positive allosteric modulator [1]
- Zuranolone (SAGE-217) - GABAA receptor positive allosteric modulator [2]
Ndị na-anabata Orexin
[dezie | dezie ebe o si]- Seltorexant (MIN-202, JNJ,42847922, JNNJ-922) - onye na-anabata OX2 [3]
- Vornorexant (ORN-0829, TS-142) - OX1 na OX2 receptor antagonist abụọ [4]
Ndị na-anabata Melatonin
[dezie | dezie ebe o si]- Piromelatine (Neu-P11) - melatonin receptor agonist na 5-HT1A na 5-HT2D receptor agonists [5]
Nociceptin receptor agonists
[dezie | dezie ebe o si]- Sunobinop (IMB-115, IT-1315, S-117957, V-117957) - onye na-anabata nociceptin [1][2]
Hypersleepsy/narcolepsy
[dezie | dezie ebe o si]- Danavorexton (TAK-925) - OX2 receptor-selective agonist site na IV infusion[1][1]
- TAK-994 - OX2 receptor agonist pill (n'ọnụ) [6][1]
Monoaminergics
[dezie | dezie ebe o si]- Flecainide/modafinil (THN-102) - modafinil (dopamine reuptake inhibitor) na flecainide (antiarrhythmic) ngwakọta [7]
- Mazindol na-achịkwa ntọhapụ (NLS-1001, NLS-1) - norepinephrine-predominant serotonin-norepinephrin-dopamine reuptake inhibitor (SNDRI) [1]
- Reboxetine (AXS-12) - norepinephrine reuptake inhibitor (NRI) [8]
Ndị na-anabata GHB
[dezie | dezie ebe o si]Ndị na-egbochi GABAA
[dezie | dezie ebe o si]- Pentylenetetrazole (BTD-001) - GABAA receptor negative allosteric modulator [10]
Hụkwa
[dezie | dezie ebe o si]- Ndepụta ọgwụ nyocha
Ntụaka
[dezie | dezie ebe o si]- ↑ 1.0 1.1 Takeda. www.ox2rsparkleprogram.com. Archived from the original on 2019-11-15. Retrieved on 2019-11-15.